DEAGE
LIVE

Serial Number

99647697

Owner

MDTB Cells GmbH

Attorney

Andrew D. Bochner

Filing Date

Feb 11, 2026

Add to watchlist:

No watchlists yet
View on USPTO

DEAGE Trademark

Serial Number: 99647697

DEAGE is a trademark filed by MDTB Cells GmbH on February 11, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

MDTB Cells GmbH (4 trademarks)

Meißner Str. 55

Entity Type: 27

Trademark Details

Filing Date

February 11, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease; Medicinal preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses; Medicinal preparations for degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease, Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease; Medicinal preparations for Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease

Filing History

APPLICATION FILING RECEIPT MAILED
Feb 11, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
NEW APPLICATION ENTERED
Feb 11, 2026 NWAP